
The Global Tobacco and Nicotine Forum (GTNF) was held in Seoul, South Korea from September 19th to 21st, 2023. GTNF is a well-known forum in the field of tobacco and nicotine, providing a unique platform for industry development and innovation. The theme of this year's forum was "Change the Conversation. Change the Outcome." Prominent figures such as Brian King, Director of the FDA Tobacco Center, Adam Afriyie, Member of the UK Windsor Parliament, Colin Mendelsohn, Chair of the Australian Tobacco Harm Reduction Association, and representatives from BAT, PMI, JUUL, and other companies participated in the event.

The Global Tobacco and Nicotine Forum (GTNF) serves as a crucial platform for the tobacco and nicotine industry, bringing together major regulatory bodies, key tobacco companies, and industry experts to engage in dialogue on the future development of the sector. During the event, 2FIRSTS attended and provided comprehensive coverage, conducting interviews with important guests and compiling their perspectives into a cohesive document to assist industry professionals in accessing the core discussions of the forum. This coverage handbook will be released today.

The manual includes a collection of 16 exceptional articles, covering three categories: exclusive interviews with invited guests, overviews of guest speakers' thematic speeches, and summaries of viewpoints from group discussions. It provides readers with cutting-edge information on the tobacco and nicotine industry from various perspectives such as regulatory supervision, protection of minors, and product development trends. It is beneficial for readers to gain a profound understanding of market dynamics and grasp future trends in the industry.
As a leading media outlet and think tank in the field of aerosol technology, 2FIRSTS will continue to report on important events within the industry and maintain a high level of focus on this sector. We will also continue to engage in conversations with key figures in order to drive ongoing innovation and progress in the tobacco and nicotine field, shaping the future of this industry together.
Click to download the electronic version of the report collection.
Regarding 2FIRSTS
2FIRSTS, established in 2022, is a globally renowned vaporization technology media and think tank, with news centers located in Shenzhen, London, New York, and other cities. 2FIRSTS focuses on major reporting and research related to the global vaporization industry, providing the latest information and analysis to regulatory authorities, supply chains, brands, channel merchants, entrepreneurs, research institutions, and industry organizations. The exhibition coverage of 2FIRSTS spans the globe, with over ten on-site reports annually and partnerships with major global trade shows.
Notice
1. This article is provided exclusively for professional research purposes related to industry, technology and policy. Any reference to brands or products is made solely for the purpose of objective description and does not constitute an endorsement, recommendation, or promotion of any brand or product.
2. The use of nicotine products, including but not limited to cigarettes, e-cigarettes, and heated tobacco products, is associated with significant health risks. Users are required to comply with all relevant laws and regulations in their respective jurisdictions.
3. This article is strictly restricted from being accessed or viewed by individuals under the legal age.
Copyright
This article is either an original work by 2Firsts or a reproduction from third-party sources with the original source clearly indicated. The copyright and usage rights of this article belong to 2Firsts or the original source. Unauthorized reproduction, distribution, or any other unauthorized use of this article by any entity or individual is strictly prohibited. Violators will be held legally responsible. For copyright-related matters, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have utilized AI to enhance translation and editing efficiency. However, due to technical limitations, errors may occur. Readers are advised to refer to the sources provided for more accurate information.
This article should not be used as a basis for any investment decisions or advice, and 2Firsts assumes no direct or indirect liability for any errors in the content.